NICA — Nanologica AB (publ) Income Statement
0.000.00%
Last trade - 00:00- SEK103.10m
- SEK121.02m
- SEK21.13m
Annual income statement for Nanologica AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | SAS | SAS | SAS | SAS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 12.9 | 1.55 | 1.44 | 14.5 | 21.1 |
| Cost of Revenue | |||||
| Gross Profit | 4.92 | 3.23 | -0.076 | 4.29 | 4.3 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 53.6 | 52.4 | 71.4 | 73.8 | 67.9 |
| Operating Profit | -40.7 | -50.9 | -70 | -59.3 | -46.8 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -44.8 | -55.2 | -75.2 | -65.6 | -51.3 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -44.8 | -55.2 | -75.2 | -65.6 | -51.3 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -44.8 | -55.2 | -75.2 | -65.6 | -51.3 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -44.8 | -55.2 | -75.2 | -65.6 | -51.3 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -1.52 | -1.73 | -1.71 | -1.2 | -0.602 |
| Dividends per Share |